Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?

Mult Scler. 2013 Oct;19(11):1550. doi: 10.1177/1352458513490549. Epub 2013 May 21.
No abstract available

Publication types

  • Comment

MeSH terms

  • Brain / pathology*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Neuromyelitis Optica / drug therapy*
  • Neuromyelitis Optica / pathology*
  • Propylene Glycols / adverse effects*
  • Sphingosine / analogs & derivatives*

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Sphingosine